EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation analysis of serum IL1RL1, DAPPER5, and MFGF with poor prognosis in patients with heart failure

Cheng Yu, Suyan Cao, Ying Zhang, Yuyu Zhao, Menghao Dong, Yulong Liu

Journal of Medical Biochemistry · 2026 · 45 (7) · 1605-1614

DOI: 10.5937/jomb0-64000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Biochemistry, 2026. Verfasst von Cheng Yu und 5 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To explore the predictive value of the combined effect of serum Interleukin-1 Receptor-like 1 (IL1RL1), dishevelled-associated protein 5 (DAPPER5), and Metabolic fibroblast growth factor (MFGF) on poor prognosis in patients with heart failure with preserved ejection fraction (HFpEF).

Methods

The study group comprised 382 HFpEF patients diagnosed and treated at this facility between July 2023 and August 2025. The control group consisted of 382 additional healthy individuals who were physically examined at the same hospital during the same time period. Patients were monitored for a year following their release from therapy. The poor prognosis group comprised patients who had adverse cardiovascular events throughout the follow-up period, while the good prognosis group included the remaining patients. Each research participant’s serum levels of IL1RL1, DAPPER5, and MFGF were assessed using an enzyme-linked immunosorbent assay. Using multivariate logistic analysis, the factors influencing the poor prognosis of HFpEF patients were investigated. A receiver operating characteristic (ROC) curve was developed to evaluate the predictive value of serum IL1RL1, DAPPER5, and MFGF, both independently and in combination, for a poor prognosis in patients with HFpEF.

Results

While the study group’s serum DAPPER5 level was lower than the control group’s, the study group’s serum IL1RL1 and MFGF levels were higher. There was a statistically significant change (P<0.05). When comparing serum levels of IL1RL1 and MFGF among individuals with varying grades of cardiac function, Grade II patients had considerably lower levels than Grade III and Grade IV patients (P<0.05). Compared with Grade III and Grade IV patients, participants with Grade II cardiac function showed considerably higher serum DAPPER5 levels (P<0.05). The poor-prognosis group had 136 patients, while the favourable-prognosis group had 246. The percentage of patients with grade IV cardiac function and the levels of serum IL1RL1, MFGF, red cell volume distribution width (RDW), and serum creatinine (Scr) were higher in the bad-prognosis group, whereas the level of serum DAPPER5 was lower in the good-prognosis group. Multivariate logistic regression analysis revealed that elevated DAPPER5 levels were protective factors for poor prognosis in patients with HFpEF (P<0.05), whereas cardiovascular function grade IV, elevated RDW, and elevated levels of Scr, IL1RL1, and MFGF were risk factors for poor prognosis. The results of the ROC curve analysis showed that the combined prediction of the three indicators for poor prognosis in patients with HFpEF had an area under the curve (AUC) of 0.950, which was higher than the AUC of serum IL1RL1, DAPPER5, and MFGF alone (Z=2.682, 2.706, and 2.714; all P<0.05).

Conclusion

While DAPPER5 levels were significantly lower in patients with HFpEF, serum levels of IL1RL1 and MFGF were significantly higher. When all three indicators are detected together, there is clinical utility in predicting a poor prognosis in patients with HFpEF.

Zitieren

APA

Yu, C., Cao, S., Zhang, Y., Zhao, Y., Dong, M., & Liu, Y. (2026). Correlation analysis of serum IL1RL1, DAPPER5, and MFGF with poor prognosis in patients with heart failure. Journal of Medical Biochemistry, 45(7), 1605-1614. https://doi.org/10.5937/jomb0-64000

Vancouver

Yu C, Cao S, Zhang Y, Zhao Y, Dong M, Liu Y. Correlation analysis of serum IL1RL1, DAPPER5, and MFGF with poor prognosis in patients with heart failure. Journal of Medical Biochemistry. 2026;45(7):1605-1614. doi:10.5937/jomb0-64000

BibTeX
@article{Yu2026,
  author = {Yu, Cheng and Cao, Suyan and Zhang, Ying and Zhao, Yuyu and Dong, Menghao and Liu, Yulong},
  title = {Correlation analysis of serum IL1RL1, DAPPER5, and MFGF with poor prognosis in patients with heart failure},
  journal = {Journal of Medical Biochemistry},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {1605--1614},
  doi = {10.5937/jomb0-64000}
}
Kostenlos starten →